LAVA Therapeutics N.V.

📍 Utrecht, Netherlands🗓 Founded 2016👥 79 employees💰 Last funded Sep 2020
Biotechnology Research🌐 lavatherapeutics.com
Website LinkedIn
At LAVA, we are focused on applying our expertise in gamma-delta T-cell engagers (TCEs) to transform cancer therapy. We refer to our compounds as gamma-delta bispecific T-cell engagers, or gamma-delta bsTCEs. Our platform generates therapeutics that specifically activate a unique and relatively abundant effector gamma-delta T-cell subset called Vγ9Vδ2 (Vgamma9-Vdelta2) T-cells that have the ability to trigger activity of immune cells of both the innate and adaptive immune system. Our gamma-delta bsTCEs have demonstrated superior efficacy and safety profiles compared to other bsTCE approaches in preclinical studies and show preferential activity against tumor cells thereby potentially limiting toxicity in healthy tissue. To date, we are the only company developing bispecific gamma-delta T-cell engaging antibodies for the treatment of cancer. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor specific antigen CD1d, which can be overexpressed in multiple myeloma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML), among other tumor types. LAVA-051 will enter a Phase I/IIa study in 1Q21.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Netherlands
1
Hong Kong SAR
1
Frequently asked questions
Who invested in LAVA Therapeutics N.V.?
LAVA Therapeutics N.V. has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did LAVA Therapeutics N.V. last raise funding?
The most recent investment in LAVA Therapeutics N.V. recorded on gritt.io was in September 2020.
When was LAVA Therapeutics N.V. founded?
LAVA Therapeutics N.V. was founded in 2016.
What industry is LAVA Therapeutics N.V. in?
LAVA Therapeutics N.V. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is LAVA Therapeutics N.V. based?
LAVA Therapeutics N.V. is headquartered in Utrecht, Netherlands.